首页> 外文OA文献 >Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients

【2h】

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients

机译：类似于肝素治疗的患者的血浆中血浆中的预氨基醛含量更始终如一地将工程化病毒纳米粒子反转肝素抗胰岛素

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andrew J. Gale; Darlene J. Elias; Patricia M. Averell; Paul S. Teirstein; Mitchell Buck; Steven D. Brown; Zinaida Polonskaya; Andrew K. Udit; M.G. Finn;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Injection Site Erythema in a Patient on Therapeutic Anticoagulation with Low Molecular Weight Heparin after Mechanical Aortic Valve Replacement: A Rare Presentation of Heparin- and Protamine-Induced Thrombocytopenia [J] . Caroline Holaubek, Paul Simon, Sabine Eichinger-Hasenauer, Case Reports in Immunology . 2020,第1期

机译：在机械主动脉瓣膜置换后，用低分子量肝素治疗抗凝治疗抗凝治疗抗凝治疗抗凝液的注射部位红斑：肝素和protamine诱导血小板减少症的罕见呈递
2. Heparin Binding to an Engineered Virus-like Nanoparticle Antagonist [J] . Cheong Ho Yong, Groner Myles, Hong Kevin, Biomacromolecules . 2017,第12期

机译：肝素与工程化病毒样纳米粒子拮抗剂结合
3. Improved Survival of Full-Thickness Skin Graft With Low-Molecular Weight Heparin-Protamine Micro/Nanoparticles Including Platelet-Rich Plasma [J] . Takabayashi Yuki, Ishihara Masayuki, Kuwabara Masahiro, Annals of Plastic Surgery . 2017,第5期

机译：用低分子量肝素 - 预蛋白微/纳米颗粒改善全厚皮肤移植物的存活包括富含血小板的血浆
4. Engineered virus-like nanoparticle heparin antagonists [C] . Udit Andrew K. Annual Conference of Japanese Society for Medical and Biological Engineering;Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2013

机译：工程病毒样纳米颗粒肝素拮抗剂
5. Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients [O] . Andrew J. Gale, Darlene J. Elias, Patricia M. Averell, -1

机译：类似于肝素治疗的患者的血浆中血浆中的预氨基醛含量更始终如一地将工程化病毒纳米粒子反转肝素抗胰岛素
6. Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade [O] . Marion Durand, Thomas Lecompte, Marie Hacquard, 2008

机译：肝素诱导的血小板减少症和心肺旁路：抗凝肝素和GPIIB / IIIa抑制剂促毒物和GPIIB / IIIA抑制剂，并且由于持久的血小板阻滞而成功地使用RFVIIa用于抗蛋白酶出血的RFVIIa
7. Treatments for Reversing Warfarin Anticoagulation in Patients with Acute Intracranial Hemorrhage: A Structured Literature Review [R] . Bechtel, B. F., Nunez, T. C., Lyon, J. A., 2011

机译：急性颅内出血患者逆转华法林抗凝治疗：结构性文献综述

Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients

著录项

引文网络

相似文献

相关主题

期刊订阅